We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Biosensor Chip Detects SNPs with Higher Sensitivity

By LabMedica International staff writers
Posted on 24 Jul 2018
Print article
Image: An illustration of graphene-based single nucleotide polymorphism (SNP) detection chip wirelessly transmitting signal to a smartphone (Photo courtesy of Professor Ratnesh Lal, PhD).
Image: An illustration of graphene-based single nucleotide polymorphism (SNP) detection chip wirelessly transmitting signal to a smartphone (Photo courtesy of Professor Ratnesh Lal, PhD).
A single nucleotide polymorphism (SNP) is the change in a single nucleotide base (A, C, G or T) in the DNA sequence and it is the most common type of genetic mutation. While most SNPs have no discernible effect on health, some are associated with increased risk of developing pathological conditions such as cancer, diabetes, heart disease, neurodegenerative disorders, autoimmune and inflammatory diseases.

Electronic DNA‐biosensor with a single nucleotide resolution capability is highly desirable for personalized medicine. However, existing DNA‐biosensors, especially SNP detection systems, have poor sensitivity and specificity and lack real‐time wireless data transmission. DNA‐tweezers with graphene field effect transistor (FET) have been used for SNP detection and data are transmitted wirelessly for analysis.

Scientists at the University of California San Diego (La Jolla, CA, USA) have developed a chip that can detect a type of genetic mutation known as a single nucleotide polymorphism (SNP) and send the results in real time to a smartphone, computer, or other electronic device. The chip is at least 1,000 times more sensitive at detecting an SNP than current technology. The chip essentially captures a strand of DNA containing a specific SNP mutation and then produces an electrical signal that is sent wirelessly to a mobile device.

The device consists of a graphene field effect transistor with a specially engineered piece of double stranded DNA attached to the surface. This piece of DNA is bent near the middle and shaped like a pair of tweezers. One side of these so-called "DNA-tweezers" codes for a specific SNP. Whenever a DNA strand with that SNP approaches, it binds to that side of the DNA-tweezers, opening them up and creating a change in electrical current that is detected by the graphene field effect transistor.

What makes the new chip so sensitive is the design of the DNA-tweezers. When the SNP-containing strand binds, it opens up the DNA-tweezers, changing their geometry so that they become almost parallel to the graphene surface. This brings the net electric charge of the DNA close to the graphene surface, giving a larger signal. In contrast, the DNA probe built into the previous chip has a structure that cannot be brought closer to the graphene surface, so it generates a weaker signal upon binding an SNP-containing strand.

Ratnesh Lal, PhD, a professor of bioengineering, mechanical engineering and materials science, and senior author of the study, said, “Miniaturized chip-based electrical detection of DNA could enable in-field and on-demand detection of specific DNA sequences and polymorphisms for timely diagnosis or prognosis of pending health crises, including viral and bacterial infection-based epidemics.” The study was published on July 9, 2018, in the journal Advanced Materials.

Related Links:
University of California San Diego

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultra-Low Temperature Freezer
iUF118-GX
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.